FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Micro Labs Clobazam Tablets 10mg Recall

Clobazam Tablets 10mg, 100-count bottle, Rx Only, Manufactured by: Micro Labs Limited G…

Micro Labs Limited · Verna, N/A

Risk level
Class II
Reported by FDA
Feb 28, 2024
Recall ID
D-0348-2024
Check your lot numberHow we source this data

Summary

Micro Labs recalled Clobazam Tablets 10mg starting Feb 12, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0348-2024 on Feb 28, 2024. Reason: CGMP Deviations: Out of specification for residual solvents. Status: Ongoing.

Why it was recalled

CGMP Deviations: Out of specification for residual solvents.

Product description

Clobazam Tablets 10mg, 100-count bottle, Rx Only, Manufactured by: Micro Labs Limited Goa-403 722, India. Manufactured for: Micro Labs USA, Inc. Somerset, NJ 08873. NDC 42571-315-01

Lot numbers, UPCs & expiration codes

ZOAG043

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0348-2024
Classification
Class II
Status
Ongoing
Recall initiated
Feb 12, 2024
FDA report date
Feb 28, 2024
Quantity
24,768 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Micro Labs Limited

Original FDA data

Every field from FDA enforcement report D-0348-2024, exactly as published.

Show all FDA fields
City
Verna
Status
Ongoing
Country
India
Event ID
93975
Address
Plot# S - 155
Address (line 2)
& N1 Phase Iii & Phase Iv; Verna Ind Estate Road
Code information
ZOAG043
Report date
Feb 28, 2024
Product type
Drugs
Recall number
D-0348-2024
Classification
Class II
Recalling firm
Micro Labs Limited
Product quantity
24,768 bottles
Reason for recall
CGMP Deviations: Out of specification for residual solvents.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Clobazam Tablets 10mg, 100-count bottle, Rx Only, Manufactured by: Micro Labs Limited Goa-403 722, India. Manufactured for: Micro Labs USA, Inc. Somerset, NJ 08873. NDC 42571-315-01
Distribution pattern
Nationwide in the USA
Recall initiation date
Feb 12, 2024
Initial firm notification
Letter
Center classification date
Feb 22, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0348-2024, published Feb 28, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls